Last €0.12 EUR
Change Today -0.02 / -14.60%
Volume 4.3K
LAVI On Other Exchanges
Symbol
Exchange
Athens
Berlin
As of 10:10 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Athanase Lavidas Ph.D.

Chairman, Chief Executive Officer, Member of Audit Committee and Member of Corporate Committee, Lavipharm S.A.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 2 different organizations across 2 different industries.

See Board Relationships
66--

Background*

Dr. Athanase Lavidas, Ph.D. serves as the Chief Executive Officer, President and Managing Director of Lavipharm S.A. Dr. Lavidas has a global perspective of Ariad Pharmaceuticals Inc. His thirty years of experience in international pharmaceutical marketing and business, as well as extensive background in drug-delivery technologies is a new perspective. As a successful entrepreneur, he has built a highly profitable and innovative pharmaceutical company based in southern ...

Read Full Background

Corporate Headquarters*

Agias Marinas Street
Paiania, -- 190 02

Greece

Phone: 30 210 66 91 000
Fax: 30 210 66 42 310

Board Members Memberships*

Chairman, Chief Executive Officer, Member of Audit Committee and Member of Corporate Committee
2003-Present
Independent Director, Chairman of Nominating & Corporate Governance Committee, Member of Executive Committee and Member of Compensation Committee

Education*

PhD
Ohio University
MS
Ludwig-Maximilians-Universität München
BS
Ludwig-Maximilians-Universität München
MBA
Institut Superieur De Marketing

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LAVI:GA €0.12 EUR -0.02

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LAVIPHARM S.A., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.